Sean D. Buckley
Technik-/Wissenschafts-/F&E-Leiter bei IMMUNOCORE HOLDINGS PLC
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| John Bell | M | 72 | 9 Jahre | |
| Robert Perez | M | 59 | 5 Jahre | |
| Kristine Peterson | F | 64 | 7 Jahre | |
| Travis Coy | M | 43 | 5 Jahre | |
| Roy Herbst | M | 60 | 3 Jahre | |
| Peter Ratcliffe | M | 69 | 4 Jahre | |
| Bahija Jallal | M | 62 | 5 Jahre | |
| Lily Hepworth | F | - | 6 Jahre | |
| Brian DiDonato | M | 57 | 4 Jahre | |
| Mary Spellman | M | 62 |
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | 4 Jahre |
| Andrea Kistner | F | - |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | 4 Jahre |
| Jeffrey G. Hesselberg | M | 65 |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | 4 Jahre |
| John Goll | M | - | 1 Jahre | |
| Tina St. Leger | F | 56 | 2 Jahre | |
| David Berman | M | - | 5 Jahre | |
| Mohammed Dar | M | - | 5 Jahre | |
| John Trainer | M | 50 | 1 Jahre | |
| Ralph Torbay | M | - | 3 Jahre | |
| Siddharth Kaul | M | 63 | 2 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Kimberly M. Smith | F | 47 | 3 Jahre | |
| Gregory Wujek | M | 62 |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | 5 Jahre |
| David M. Pernock | M | 69 | 7 Jahre | |
| Lisa A. Embon | F | 60 | - | |
| Douglas Swirsky | M | 54 | 6 Jahre | |
| Michael Marino | M | 48 | 2 Jahre | |
| Keith Goldan | M | 52 | 2 Jahre | |
| Gregory Weaver | M | 68 | 1 Jahre | |
| George J. Korkos | M | 92 | 2 Jahre | |
| Christine St. Clare | F | 73 | 6 Jahre | |
| Karen Casey | F | - | 7 Jahre | |
| Robert Langer | M | 74 | 3 Jahre | |
| Alfred T. Lane | M | - | - | |
| Julian P. Kirk | M | 50 | 7 Jahre | |
| William Zuo | M | 62 | 3 Jahre | |
| Marcus E. Smith | M | 69 | 7 Jahre | |
| Pamela A. Swiggard | F | - | 1 Jahre | |
| Robert Sheroff | M | 69 | 2 Jahre | |
| Gregory MacMichael | M | 68 |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 22 | 57,89% |
| Vereinigtes Königreich | 16 | 42,11% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Sean D. Buckley
- Persönliches Netzwerk
